TG Therapeutics (TGTX) Announces Presentation of Data for BRIUMVI in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum

Go back to TG Therapeutics (TGTX) Announces Presentation of Data for BRIUMVI in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum
TG THERAP (NASDAQ: TGTX) Delayed: 49.52 +1.47 (3.06%)
Previous Close $48.05    52 Week High $14.87 
Open $48.05    52 Week Low $4.90 
Day High $50.41    P/E N/A 
Day Low $47.96    EPS $-0.67 
Volume 2,548,896